2026-10-25T14:28:37Z https://nostr.now Clinical Advisory Network on Sex and Gender https://nostr.now/npub1w3ppwgp3nd86rnntvyjmgj3hrvjq96u8xrmfls7m7p39reh5xfdshm5ett https://pbs.twimg.com/profile_images/1505563224703389702/PzDDCmfW_400x400.jpg https://pbs.twimg.com/profile_images/1505563224703389702/PzDDCmfW_400x400.jpg https://nostr.now/nevent1qqsv9qhf50p9uq03ywy9smpkd6wvvlujwyrahfvtwpx06s24wtcqp9czyp6yy9eqxxd5lgwwddsjtdz2xudjgqhtsuc0d87rm0cxy50x7se9k7gu4mu The puberty blocker trial is currently under scrutiny by the regulators and also faces a judicial review. Despite these hurdles it may still go ahead. CAN-SG believes the risks far outweigh the benefits. One of the most important risks is of irreversible changes to adolescents&#39;<br/> <img src="https://pbs.twimg.com/media/HIHuHvYXQAETL7y.jpg"> <br/> 2026-05-12T13:08:36Z